Choice of Corticosteroids for the Management of Acute Rhinosinusitis: Marketing and Pharmacoeconomic Assessment of the Modern Markete

Solomko, D. and Solomko, Yu. and Velychko, O. and Makarenko, O. (2020) Choice of Corticosteroids for the Management of Acute Rhinosinusitis: Marketing and Pharmacoeconomic Assessment of the Modern Markete. The scientific heritage (№ 44). pp. 44-46. ISSN 9215-0365

Text CHOICE OF CORTICOSTEROIDS FOR THE MANAGEMENT OF ACUTE RHINOSINUSITIS MARKETING AND PHARMACOECONOMIC ASSESSMENT OF THE MODERN MARKETE .pdf Download (151kB)

Abstract

Ukrainian market for drugs of the first line of allergic rhinitis treatment is represented by imported nasal corticosteroids (the leaders of representatives are the countries of India and Belgium for 17.4% of the total group assortment). Nasal corticosteroids are widely represented by active ingredients, namely, 45eclomethasone, fluticasone, mometasone and combination agents, with a total of 23 trading positions in the market. The FORINEX, domestic spray produced by PHARMAC is the only representative of the R01AD group, but it is not a drug of choice among the nasal corticosteroids in terms of pricing and cost.

Item Type:	Article
Uncontrolled Keywords:	allergic rhinitis, pharmacoeconomic assessment, nasal corticosteroids, pharmacotherap.
Subjects:	Social medicine, organization and health economics
Divisions:	Faculty of Postgraduate Education > Department of social medicine, public health and health care management
Depositing User:	Анастасия Жигар
Date Deposited:	10 Nov 2020 07:50
Last Modified:	10 Nov 2020 07:50
URI:	http://repo.dma.dp.ua/id/eprint/5939

Actions (login required)

View Item